286.58
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PODD Giù?
Forum
Previsione
Insulet Corporation Borsa (PODD) Ultime notizie
What institutions are buying Insulet Corporation stock nowExplosive portfolio gains - jammulinksnews.com
What to Expect From Insulet's Q2 2025 Earnings Report - Yahoo Finance
Tubeless Insulin Pumps Market Attracts Startups Amid Booming - openPR.com
Insulet granted EU-wide injunction against EOFlow in default decision by UPC - MLex
Insulin Pumps Market Outlook Report 2025, with Leading - GlobeNewswire
What drives Insulet Corporation stock priceTriple-digit wealth increases - jammulinksnews.com
Is Insulet Corporation a good long term investmentFree Predictions - jammulinksnews.com
What analysts say about Insulet Corporation stockSuperior returns - jammulinksnews.com
What To Expect From Insulet's Q2 2025 Earnings Report - Barchart.com
Insulet Corporation Stock Analysis and ForecastFree Wealth Management Insights - jammulinksnews.com
Digital Diabetes Management Market is projected to reach US$ - openPR.com
$1000 Invested In Insulet 10 Years Ago Would Be Worth This Much Today - Benzinga
Navigating the Crossroads: Insulet's Short-Term Volatility and Long-Term Growth Potential - AInvest
Insulet's PODD Stock Plunges 2.72% Amid Market Uncertainty - AInvest
Smart Pumps Market is projected to reach USD 19.96 billion by 2033 - openPR.com
Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Leading Insulin Pump Maker Insulet to Release Q2 2025 Results August 7Key Details for Investors - Stock Titan
Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire
Trading (PODD) With Integrated Risk Controls - news.stocktradersdaily.com
How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks? - MSN
5 Insightful Analyst Questions From Insulet’s Q1 Earnings Call - Yahoo Finance
When Should You Buy Insulet Corporation (NASDAQ:PODD)? - Yahoo Finance
Pump manufacturers: Patches are the fix for low AID uptake - BioWorld MedTech
Insulet Stock Plummets 30.61% with $196M Trading Volume Ranking 493rd Amid Omnipod 5 Recall - AInvest
How Is Insulet's Stock Performance Compared To Other Medical Devices Stocks? - Barchart.com
Insulet’s Eric Benjamin shares update on automated insulin delivery system - MedTech Dive
5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions - Business Wire
Truist bullish on diabetes companies citing potential market growth - MSN
Insulet’s SWOT analysis: patch pump leader’s stock poised for growth By Investing.com - Investing.com South Africa
Insulet’s SWOT analysis: patch pump leader’s stock poised for growth - Investing.com
Analyst Predicts Strong Growth for Insulet (PODD) with Buy Ratin - GuruFocus
Insider Sell: Dan Manea Sells 1,300 Shares of Insulet Corp (PODD) - GuruFocus
Insulet, EyePoint & NanoDx receive $2M in tax incentives to create life sciences jobs - Worcester Business Journal
Insulet (PODD) Rated 'Buy' by Truist Securities; Price Target Set at $365 | PODD Stock News - GuruFocus
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):